These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20877301)

  • 21. Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation.
    Krapivner S; Popov S; Chernogubova E; Hellénius ML; Fisher RM; Hamsten A; van't Hooft FM
    J Clin Endocrinol Metab; 2008 May; 93(5):1995-2001. PubMed ID: 18319320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
    Scheltema Beduin AA; Swets M; Machielsen M; Korver N;
    J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.
    Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Scheffer H; Egberts AC
    J Clin Psychopharmacol; 2007 Aug; 27(4):338-43. PubMed ID: 17632216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of the
    Vanwong N; Sukasem C; Unaharassamee W; Jiratjintana N; Na Nakorn C; Hongkaew Y; Puangpetch A
    J Pers Med; 2021 Sep; 11(10):. PubMed ID: 34683084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis.
    Zhang C; Zhang Y; Cai J; Chen M; Song L
    Pharmacogenomics J; 2017 Jan; 17(1):92-97. PubMed ID: 26503818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study.
    Mulder H; Cohen D; Scheffer H; Gispen-de Wied C; Arends J; Wilmink FW; Franke B; Egberts AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):16-20. PubMed ID: 19142101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gene-gene interaction of INSIG-SCAP-SREBP pathway on the risk of obesity in Chinese children.
    Liu FH; Song JY; Shang XR; Meng XR; Ma J; Wang HJ
    Biomed Res Int; 2014; 2014():538564. PubMed ID: 25028659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome.
    Boiko AS; Pozhidaev IV; Paderina DZ; Mednova IA; Goncharova AA; Fedorenko OY; Kornetova EG; Semke AV; Bokhan NA; Loonen AJM; Ivanova SA
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients.
    Kuzman MR; Medved V; Bozina N; Hotujac L; Sain I; Bilusic H
    Psychiatry Res; 2008 Sep; 160(3):308-15. PubMed ID: 18718676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is rs7566605, a SNP near INSIG2, associated with body mass in a randomized clinical trial of antipsychotics in schizophrenia?
    Skelly T; Pinheiro AP; Lange LA; Sullivan PF
    Mol Psychiatry; 2007 Apr; 12(4):321-2. PubMed ID: 17389899
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study.
    Wampers M; Hanssens L; van Winkel R; Heald A; Collette J; Peuskens J; Reginster JY; Scheen A; De Hert M
    Eur Neuropsychopharmacol; 2012 Jan; 22(1):17-26. PubMed ID: 21511441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotics and metabolic outcomes in Chinese patients: a comparison of olanzapine and risperidone.
    Lee E; Leung CM
    J Clin Psychopharmacol; 2008 Dec; 28(6):707-9. PubMed ID: 19011445
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
    Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
    Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study.
    Cerit C; Vural M; Bos Gelmez SÜ; Ozten E; Aker AT; Yıldız M
    Psychopharmacol Bull; 2010; 43(4):22-36. PubMed ID: 21240150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association between LXRα and LXRβ gene polymorphisms and prevalence of metabolic syndrome: a case-control study of an Iranian population.
    Rooki H; Ghayour-Mobarhan M; Haerian MS; Ebrahimi M; Azimzadeh P; Heidari-Bakavoli A; Mirfakhraei R; Tavallaie S; Mirhafez R; Ferns G; Zali MR
    Gene; 2013 Dec; 532(2):288-93. PubMed ID: 24100084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study.
    Risselada AJ; Vehof J; Bruggeman R; Wilffert B; Cohen D; Al Hadithy AF; Arends J; Mulder H
    Pharmacogenomics J; 2012 Feb; 12(1):62-7. PubMed ID: 20680028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
    Smith RC; Lindenmayer JP; Hu Q; Kelly E; Viviano TF; Cornwell J; Vaidhyanathaswamy S; Marcovina S; Davis JM
    Schizophr Res; 2010 Jul; 120(1-3):204-9. PubMed ID: 20457512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variability at the six transmembrane protein of prostate 2 locus and the metabolic syndrome: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
    Miot A; Maimaitiming S; Emery N; Bellili N; Roussel R; Tichet J; Velho G; Balkau B; Marre M; Fumeron F;
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2942-7. PubMed ID: 20382686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
    Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.
    Zhang Y; Chen M; Chen J; Wu Z; Yu S; Fang Y; Zhang C
    Psychopharmacology (Berl); 2014 May; 231(10):2211-8. PubMed ID: 24448899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.